SRR1359388
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- SPERMATOGENESIS+0.312
- OXIDATIVE_PHOSPHORYLATION+0.171
- KRAS_SIGNALING_DN+0.163
- HEDGEHOG_SIGNALING+0.136
- MYOGENESIS+0.001
- UV_RESPONSE_DN-0.033
- BILE_ACID_METABOLISM-0.044
- APICAL_SURFACE-0.064
- HEME_METABOLISM-0.074
- FATTY_ACID_METABOLISM-0.087
Top 10 suppressed
- IL6_JAK_STAT3_SIGNALING-0.591
- INTERFERON_ALPHA_RESPONSE-0.581
- INTERFERON_GAMMA_RESPONSE-0.538
- TNFA_SIGNALING_VIA_NFKB-0.521
- ALLOGRAFT_REJECTION-0.483
- MYC_TARGETS_V1-0.463
- INFLAMMATORY_RESPONSE-0.453
- E2F_TARGETS-0.424
- G2M_CHECKPOINT-0.418
- ANGIOGENESIS-0.416
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1477197 | GTEX | — | 0.975 |
| 2 | SRR1335651 | GTEX | — | 0.975 |
| 3 | SRR1477634 | GTEX | — | 0.974 |
| 4 | SRR1474065 | GTEX | — | 0.971 |
| 5 | SRR1367870 | GTEX | — | 0.970 |
| 6 | SRR1465356 | GTEX | — | 0.969 |
| 7 | SRR1070986 | GTEX | — | 0.966 |
| 8 | SRR1370619 | GTEX | — | 0.963 |
| 9 | SRR1397094 | GTEX | — | 0.957 |
| 10 | SRR1487107 | GTEX | — | 0.957 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 5 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| SPERMATOGENESIS | 0.312 | Inavolisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.171 | Remibrutinib | — uncovered |
| KRAS_SIGNALING_DN | 0.163 | Remibrutinib | — uncovered |
| HEDGEHOG_SIGNALING | 0.136 | Inavolisib | — uncovered |
| MYOGENESIS | 0.001 | Inavolisib | — uncovered |